Results 81 to 90 of about 8,035 (194)

The correlation between the percentages of Th17, Th22 and Th17/Th22 cells in patients.

open access: yes, 2013
The potential correlations among different subsets of CD4+ T cells were analyzed by Spearman rank correlation test. Data shown are the mean values of individual patients (n = 27).
Di Peng (432822)   +4 more
core   +1 more source

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment

open access: yes
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 260-263, March 2025.
Celeste M. Boesjes   +7 more
wiley   +1 more source

Effect of Abrocitinib on the Skin Microbiome in Patients With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, Volume 81, Issue 10, Page 3599-3607, October 2026.
Atopic dermatitis (AD) is characterized by microbial dysbiosis. This study aimed to evaluate the effects of abrocitinib, a JAK1‐selective inhibitor, on the skin microbiome and its potential associations with clinical outcomes in patients with AD. Abrocitinib treatment was associated with increased skin microbial diversity and decreased Staphylococcus ...
Madeline Kim   +10 more
wiley   +1 more source

Loss of Th17, Th22, and Th17/Th22 cell function correlates with colorectal immune activation, soluble markers of inflammation, and levels of CD4+ T-cells.

open access: yes, 2016
Correlations between Th17, Th22, and Th17/Th22 cell function and plasma viral loads (copies viral RNA per mL of plasma) (A,B), absolute number of CD4+ T-cells (C), levels of activated colorectal (HLA-DR+CD38+) CD4+ T-cells (D,E), the level of ...
Luca Micci (427502)   +7 more
core   +1 more source

Elevated Th22 cells correlated with Th17 cells in patients with high liver stiffness in nonalcoholic fatty liver disease

open access: yesEuropean Journal of Inflammation, 2018
The aims of this article are to investigate the effects of Th22 and Th17 cells and plasma cytokines in patients with nonalcoholic fatty liver disease (NAFLD) and to examine the correlation between Th22 and Th17 cells levels and disease progression. Blood
Si-Biao Su   +3 more
doaj   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, Volume 56, Issue 10, Page 1162-1176, October 2026.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Development of a Rapid, Field‐Based Method and a Real‐Time Multiplex PCR for Simultaneous Detection of Multiple Forestry Phytophthora Species

open access: yesForest Pathology, Volume 56, Issue 5, October 2026.
ABSTRACT There are currently several Phytophthora species that are of major concern for forestry. Three of these species: P. pluvialis, P. pseudosyringae and P. ramorum, share a similar host range across the British Isles and display similar symptoms and disease progression. As P. pluvialis and P. ramorum are regulated pathogens in Great Britain, early
Amy Eacock   +5 more
wiley   +1 more source

Characterization of Mycobacterium tuberculosis-specific Th22 cells and the effect of tuberculosis disease and HIV coinfection.

open access: yes, 2022
The development of a highly effective tuberculosis (TB) vaccine is likely dependent on our understanding of what constitutes a protective immune response to TB.
Mohau S Makatsa (13198572)   +5 more
core   +1 more source

Identifizierung und Charakterisierung neuer regulierender Faktoren von Th17 und Th22-Zellen

open access: yes, 2018
This study identified an upregulated expression of LINGO4 in Th17 cells and FOXO4 in IL-22 producing as well as Th22 cells. LINGO4 expression strongly correlated with the expression of the key transcription factor of Th17 cells, RORC2, and was identified
Atenhan, Anne
core  

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

open access: yes, 2015
There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation.
Tresoldi C   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy